# FDA 483 - Lupin Limited - December 04, 2018

Source: https://www.keypedia.com/records/483/lupin-limited/4a7b4f58-35ab-46da-bb80-3ddb7dbc5325

> FDA 483 for Lupin Limited on December 04, 2018. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Lupin Limited
- Inspection Date: 2018-12-04
- Product Type: drugs
- Office Name: Division of Clinical Evidence and Analysis 1 (Clinical Policy and Quality)

## Related Documents

- [483 - 2018-12-04](https://www.keypedia.com/records/483/lupin-limited/7563e21c-3de3-472c-b7c2-896029346d00)
- [483 - 2022-11-23](https://www.keypedia.com/records/483/lupin-limited/a8b2c8e0-ce26-40d8-ba9d-12baf6bad6fc)
- [483 - 2022-11-23](https://www.keypedia.com/records/483/lupin-limited/9526924e-9742-43cf-b424-a50ea10b302e)

## Related Officers

- [Pratik S. Upadhyay](https://www.keypedia.com/people/pratik-s-upadhyay/22ff2e0b-17d4-4c91-a3f0-c7e30b7a115b)
- [June P. Page](https://www.keypedia.com/people/june-p-page/3b1ffc71-ce2e-47f5-aefe-87fd5eebc792)
- [Uneece Ranjan](https://www.keypedia.com/people/uneece-ranjan/5421503c-c77d-45ca-b67d-9336ed87c4e7)
- [Christopher S. Keating](https://www.keypedia.com/people/christopher-s-keating/94fcfd32-feb5-4b6c-80da-16202f4be01d)

Company: https://www.keypedia.com/companies/lupin-limited/122cdc90-be58-47a6-8127-004b3a6a04c3

Office: https://www.keypedia.com/offices/division-of-clinical-evidence-and-analysis-1-clinical-policy-and-quality/5f95da17-30bb-423f-b892-5ea041823fbd